Want to join the conversation?
For 3Q15, $CTXS delivered cash flow from operations of $260MM, which was $96MM higher than 3Q14. Excluding the effects of amortization of acquired product related intangible assets and stock-based compensation expense, GAAP GM was 82%, while non-GAAP GM was 85%. The company repurchased 3.9MM shares at an average price of $71.76.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?